Free Delivery Over $100
|
|
|||
|
||||
OverviewMother-to-child transmission of HIV-1 afflicts hundreds of thousands of children every year, especially in parts of the world such as sub-Saharan Africa, where HIV infection is prevalent and resources are limited. This tragic reality has spurred researchers to search for an effective, safe, and inexpensive treatment that could reduce the risk of perinatal HIV transmission. The HIVNET 012 trial was designed to provide preliminary information on the comparative safety and efficacy of two relatively simple and inexpensive short courses of oral antiretroviral treatment likely to be feasible in resource-limited settings. The resulting report identified some problems with procedures and documentation, but concluded that these issues did not compromise the results of the study. However, these issues have led to public scrutiny and continued controversy. Review of the HIVNET 012 Perinatal HIV Prevention Study critically and objectively evaluates the study's design and conduct, and assesses the impact of the initial procedural issues on the validity of the overall findings and conclusions of the trial. Table of Contents Front Matter Executive Summary 1 Introduction 2 Overview of HIVNET 012 3 Study Design, Treatment, Assignment, and Adherence to Study Regimens 4 Efficacy and Safety 5 Review of Ethical Issues 6 Response to the Charge to the Committee Appendix A: Agendas of Information-Gathering Meetings Appendix B: Comparisons to Other Perinatal HIV Prevention Studies Using NVP and AZT Appendix C: Committee Biographies Full Product DetailsAuthor: Institute of Medicine , Board on Population Health and Public Health Practice , Committee on Reviewing the HIVNET 012 Perinatal HIV Prevention Study , National Academy of SciencesPublisher: National Academies Press Imprint: National Academies Press ISBN: 9780309096515ISBN 10: 0309096510 Pages: 150 Publication Date: 05 September 2005 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of Contents1 Front Matter; 2 Executive Summary; 3 1 Introduction; 4 2 Overview of HIVNET 012; 5 3 Study Design, Treatment, Assignment, and Adherence to Study Regimens; 6 4 Efficacy and Safety; 7 5 Review of Ethical Issues; 8 6 Response to the Charge to the Committee; 9 Appendix A: Agendas of Information-Gathering Meetings; 10 Appendix B: Comparisons to Other Perinatal HIV Prevention Studies Using NVP and AZT; 11 Appendix C: Committee BiographiesReviewsAuthor InformationCommittee on Reviewing the HIVNET 012 Perinatal HIV Prevention Study, Board on Population Health and Public Health Practice Tab Content 6Author Website:Countries AvailableAll regions |
||||
